TABLE 1.
Clinical details of patients
| ID | Details of the Reaction | Age/ Sex | Sputum Classification | Time to Reaction | Time Since Reaction | Courses Before Reaction | Other Reactions |
|---|---|---|---|---|---|---|---|
| days | months | ||||||
| Piperacillin-hypersensitive patients | |||||||
| 1 | Flu-like illness | 18/male | Chronic Pseudomonas | 2 | 6 | 3 | Ceftazidime; meropenem; aztreonam |
| 2 | Maculopapular exanthema | 24/male | Chronic Pseudomonas | 11 | 5 | 9 | Sulfamethoxazole |
| 3 | Maculopapular exanthema, fever | 20/male | Chronic Pseudomonas | 9 | 8 | 3 | Ceftazidime; meropenem; aztreonam sulfamethoxazole |
| 4 | Fever, arthralgia | 29/female | Chronic Pseudomonas | 9 | 7 | 7 | Ceftazidime; meropenem |
| 5 | Maculopapular exanthema, fever | 20/male | Burkholderia cepacia | 2 | 2 | 4 | Ceftazidime |
| 6 | Maculopapular exanthema | 27/male | Chronic Pseudomonas | 5 | 3 | 3 | Ceftazidime |
| 7 | Fever, eosinophilia | 30/female | Intermittent Pseudomonas | 7 | 2 | 14 | |
| 8 | Arthralgia | 22/female | Non-Pseudomonas | 5 | 5 | 4 | Ceftazidime; Sulfamethoxazole |
| Piperacillin-tolerant patients | |||||||
| 1 | 25/male | Chronic Pseudomonas | |||||
| 2 | 22/female | Chronic Pseudomonas | |||||
| 3 | 18/female | Non-Pseudomonas | |||||
| 4 | 27/female | Chronic Pseudomonas | Sulfamethoxazole | ||||
| 5 | 26/female | Intermittent Pseudomonas | |||||